From October 1, 2023 to December 31, 2023, the company has repurchased 873,000 shares, representing 2.91% for $22.84 million. With this, the company has completed the repurchase of 2,763,000 shares, representing 9.21% for $99.38 million under the buyback announced on March 8, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.51 USD | -0.68% | -4.67% | -28.71% |
May. 03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
May. 03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.71% | 618M | |
-24.66% | 7.76B | |
+69.31% | 4.33B | |
-3.33% | 2.64B | |
+3.74% | 2.63B | |
-47.63% | 2.16B | |
-15.82% | 1.75B | |
-19.62% | 1.46B | |
+14.52% | 1.17B | |
-45.53% | 1.14B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.